2.45
Schlusskurs vom Vortag:
$2.48
Offen:
$2.49
24-Stunden-Volumen:
125.44K
Relative Volume:
0.30
Marktkapitalisierung:
$42.31M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.61%
1M Leistung:
+0.00%
6M Leistung:
-37.97%
1J Leistung:
-27.73%
Mural Oncology Plc Stock (MURA) Company Profile
Firmenname
Mural Oncology Plc
Sektor
Branche
Telefon
353 1 905 8020
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Vergleichen Sie MURA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MURA
Mural Oncology Plc
|
2.45 | 43.00M | 0 | 0 | 0 | 0.00 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-25 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2025-03-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
2024-06-28 | Eingeleitet | Rodman & Renshaw | Buy |
2024-04-04 | Eingeleitet | Morgan Stanley | Overweight |
Mural Oncology Plc Aktie (MURA) Neueste Nachrichten
Mural Oncology plc Stock Analysis and ForecastGame-changing capital returns - jammulinksnews.com
What drives Mural Oncology plc stock priceHigh-yield investments - jammulinksnews.com
Form 8.3Mural Oncology plc - Business Wire
Why Mural Oncology plc stock attracts strong analyst attentionReturn Maximized Portfolio Strategy - Newser
What analysts say about Mural Oncology plc stockExceptional market positioning - printweek.in
Is Mural Oncology plc a good long term investmentRapid-fire capital growth - jammulinksnews.com
Can Mural Oncology (NASDAQ:MURA) Afford To Invest In Growth? - Yahoo Finance
How Mural Oncology plc stock performs during market volatilityFree Investment Risk Control - Newser
What makes Mural Oncology plc stock price move sharplyFree Stock Selection with 300% Return - Newser
Geode Capital discloses 1.01% stake in Mural Oncology By Investing.com - Investing.com Nigeria
Geode Capital discloses 1.01% stake in Mural Oncology - Investing.com
Concurrent Investment Advisors LLC Makes New $28,000 Investment in Mural Oncology PLC (NASDAQ:MURA) - Defense World
BlackRock discloses 1.65% stake in Mural Oncology - Investing.com Australia
BlackRock discloses 1.65% stake in Mural Oncology By Investing.com - Investing.com Nigeria
The Vanguard Group, Inc. Discloses Interest in Mural Oncology plc - AInvest
Mural Oncology (NASDAQ:MURA) Trading 3.2% Higher – Should You Buy? - Defense World
Cancer index outperforms broader markets with 13% Q2 rebound - BioWorld MedTech
LMR Partners discloses 2.99% stake in Mural Oncology By Investing.com - Investing.com South Africa
LMR Partners discloses 2.99% stake in Mural Oncology - Investing.com
Alkermes spinoff Mural plunges on plans to halt ovarian cancer trial - MSN
Finanzdaten der Mural Oncology Plc-Aktie (MURA)
Es liegen keine Finanzdaten für Mural Oncology Plc (MURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):